Previous Article | Next Article ![]()
Journal of Clinical Microbiology, January 2000, p. 152-157, Vol. 38, No. 1
Forschungszentrum Borstel, National Reference
Center for Mycobacteria, D-23845 Borstel, Germany
Received 1 June 1999/Returned for modification 10 July
1999/Accepted 22 September 1999
The variations in biochemical as well as molecular characteristics
among several members of the Mycobacterium tuberculosis complex that are not M. tuberculosis have been assessed to
facilitate an unambiguous species identification. Altogether, 96 M. tuberculosis complex strains including 52 M. bovis isolates and 44 M. africanum isolates were
analyzed by spoligotyping. The strains could be clustered into five
spoligotype groups. All M. bovis isolates showed the
typical absence of the spacers 39 to 43 and typical biochemical
properties. However, within these strains we found a group of strains
that had a spoligotype pattern which is clearly defined by the
additional absence of spacers 3 to 16 and that were uncommonly
susceptible to pyrazinamide (PZA). This spoligotype pattern has
previously been described as being typical for a caprine genotype
because of its predominant isolation from sheep and goats. Due to the
clinical importance of PZA resistance, we propose two M. bovis subtypes: M. bovis subtype bovis,
which is resistant to PZA, and M. bovis subtype
caprae, which is susceptible to PZA. Two additional strains
that clustered in group 3 showed biochemical and genetic properties
typical for M. bovis and were also sensitive to PZA; thus,
they may represent a third PZA-susceptible M. bovis subtype. The M. africanum isolates could be clustered into
two spoligotype groups which can be differentiated from M. bovis by hybridization to spacers 39 to 43. These groups
correspond to the previously described M. africanum
subtypes I and II and can be clearly distinguished from each other by
spoligotyping and resistance to thiophen-2-carboxylic acid hydrazide.
Our results demonstrate that spoligotyping is a useful tool for
differentiation of M. bovis and M. africanum.
Moreover, we describe two PZA-susceptible M. bovis subtypes
and describe a method that facilitates an unambiguous differentiation of the two M. africanum subtypes.
0095-1137/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Differentiation among Members of the Mycobacterium
tuberculosis Complex by Molecular and Biochemical Features:
Evidence for Two Pyrazinamide-Susceptible Subtypes of
M. bovis
*
Corresponding author. Mailing address:
Forschungszentrum Borstel, National Reference Center for
Mycobacteria, Parkallee 18, D-23845 Borstel, Germany, Phone:
(49)-4537-188658. Fax: (49)-4537-188311. E-mail:
sniemann{at}fz-borstel.de.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|